What is Medtronic's remainder of fiscal year 2025?

Medtronic (MDT) reported remainder of fiscal year 2025 of $405M in Q4 2025.

How has Medtronic's remainder of fiscal year 2025 changed year-over-year?

Medtronic's remainder of fiscal year 2025 decreased by 2.2% year-over-year, from $414M to $405M.

Medtronic MDT Remainder of Fiscal Year 2025

Remainder of Fiscal Year 2025 at other companies

Medline, Inc. MDLN

——

AmgenAMGN

——

McKessonMCK

——

BiogenBIIB

——

Other financials

Income statement

See full

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

See full

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

See full

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation

See full

Market cap$101.86B-3.8%

Enterprise value$129.12B-3.2%

P/E21.2×-1.5×

P/S2.8×-0.4×

Profitability

See full

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

Returns & leverage

See full

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's remainder of fiscal year 2025.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medtronic's remainder of fiscal year 2025?: Medtronic (MDT) reported remainder of fiscal year 2025 of $405M in Q4 2025.
How has Medtronic's remainder of fiscal year 2025 changed year-over-year?: Medtronic's remainder of fiscal year 2025 decreased by 2.2% year-over-year, from $414M to $405M.